» Articles » PMID: 27994552

Exercise Training Attenuates Right Ventricular Remodeling in Rats with Pulmonary Arterial Stenosis

Abstract

Pulmonary arterial stenosis (PAS) is a congenital defect that causes outflow tract obstruction of the right ventricle (RV). Currently, negative issues are reported in the PAS management: not all patients may be eligible to surgeries; there is often the need for another surgery during passage to adulthood; patients with mild stenosis may have later cardiac adverse repercussions. Thus, the search for approaches to counteract the long-term PAS effects showed to be a current target. At the study herein, we evaluated the cardioprotective role of exercise training in rats submitted to PAS for 9 weeks. Exercise resulted in improved physical fitness and systolic RV function. Exercise also blunted concentric cavity changes, diastolic dysfunction, and fibrosis induced by PAS. Exercise additional benefits were also reported in a pro-survival signal, in which there were increased Akt activity and normalized myocardial apoptosis. These findings were accompanied by microRNA-1 downregulation and microRNA-21 upregulation. Moreover, exercise was associated with a higher myocardial abundance of the sarcomeric protein α-MHC and proteins that modulate calcium handling-ryanodine receptor and Serca 2, supporting the potential role of exercise in improving myocardial performance. Our results represent the first demonstration that exercise can attenuate the RV remodeling in an experimental PAS. The cardioprotective effects were associated with positive modulation of RV function, survival signaling pathway, apoptosis, and proteins involved in the regulation of myocardial contractility.

Citing Articles

Inhibitory effect of microRNA-21 on pathways and mechanisms involved in cardiac fibrosis development.

Khalaji A, Mehrtabar S, Jabraeilipour A, Doustar N, Rahmani Youshanlouei H, Tahavvori A Ther Adv Cardiovasc Dis. 2024; 18:17539447241253134.

PMID: 38819836 PMC: 11143841. DOI: 10.1177/17539447241253134.


Right Ventricle and Epigenetics: A Systematic Review.

Toro V, Jutras-Beaudoin N, Boucherat O, Bonnet S, Provencher S, Potus F Cells. 2023; 12(23).

PMID: 38067121 PMC: 10705252. DOI: 10.3390/cells12232693.


Editorial: Exploring new interventions in myocardial remodeling: from experimental to clinical studies.

Serra A, Vieira S, Neves Dos Santos L Front Physiol. 2023; 14:1264279.

PMID: 37601644 PMC: 10438981. DOI: 10.3389/fphys.2023.1264279.


Hypertrophy of the right ventricle by pulmonary artery banding in rats: a study of structural, functional, and transcriptomics alterations in the right and left ventricles.

Silva J, Antonio E, Neves Dos Santos L, Serra A, Feliciano R, Silva Junior J Front Physiol. 2023; 14:1129333.

PMID: 37576341 PMC: 10414540. DOI: 10.3389/fphys.2023.1129333.


More than just a small left ventricle: the right ventricular fibroblast and ECM in health and disease.

McNair B, Shorthill S, Bruns D Am J Physiol Heart Circ Physiol. 2023; 325(2):H385-H397.

PMID: 37389951 PMC: 10396282. DOI: 10.1152/ajpheart.00213.2023.


References
1.
Tchoumi J, Ambassa J, Giamberti A, Cirri S, Frogiola A, Butera G . Late surgical treatment of tetralogy of Fallot. Cardiovasc J Afr. 2011; 22(4):179-81. PMC: 3721949. DOI: 10.5830/CVJA-2010-057. View

2.
Matsui T, Nagoshi T, Rosenzweig A . Akt and PI 3-kinase signaling in cardiomyocyte hypertrophy and survival. Cell Cycle. 2003; 2(3):220-3. View

3.
Tu Y, Wan L, Fan Y, Wang K, Bu L, Huang T . Ischemic postconditioning-mediated miRNA-21 protects against cardiac ischemia/reperfusion injury via PTEN/Akt pathway. PLoS One. 2013; 8(10):e75872. PMC: 3789724. DOI: 10.1371/journal.pone.0075872. View

4.
Harston R, McKillop J, Moschella P, Van Laer A, Quinones L, Baicu C . Rapamycin treatment augments both protein ubiquitination and Akt activation in pressure-overloaded rat myocardium. Am J Physiol Heart Circ Physiol. 2011; 300(5):H1696-706. PMC: 3094075. DOI: 10.1152/ajpheart.00545.2010. View

5.
Sizarov A, Boudjemline Y . Novel materials and devices in the transcatheter management of congenital heart diseases-the future comes slowly (part 3). Arch Cardiovasc Dis. 2016; 109(5):348-58. DOI: 10.1016/j.acvd.2016.01.005. View